Enlicitide chloride

Article Information

Alias Titles: None
External Link: View on Wikipedia
Last Crawled At: July 19, 2026 at 21:26

Citation Frequency

Related Wikipedia Articles

No related Wikipedia articles found based on shared citations.

All Citations by Date

Jul 16, 2026

FDA Approves First-of-Its-Kind Cholesterol Pill, Ushering In New Wave of Treatment

wsj.com News

Merck's Lipfendra (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia

businesswire.com News

Jul 15, 2026

Merck's Lipfendra (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia

businesswire.com News

Nov 08, 2025

New Pill From Merck Could Slash Cholesterol Levels, Trials Show. The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk.

nytimes.com News